Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myeloma

Management of relapsed and refractory multiple myeloma (RRMM) remains challenging given the clinical and genetic heterogeneity of disease in this setting and the increasing therapeutic options that...